THE EFFECTS OF ALLOGENEIC MSC ADMINISTRATION ON ATHEROSCLEROTIC VESSEL WALL (EXPERIMENTAL STUDY OF TGF-β1, IL-1α, AND IL-6 ON ATHEROSCLEROTIC SPRAGUE DAWLEY RATS)

Background: Atherosclerosis is the leading cause of morbidity and mortality in the world. Mesenchymal stem cells (MSCs) are implicated in a variety of physiological and pathological processes. They may able to ameliorate atherosclerosis by interfering IL-1α, IL-6 and TGF-β1 expression. However, the...

Full description

Saved in:
Bibliographic Details
Main Author: Taufiq, Fikri (Author)
Format: Academic Paper
Published: 2014.
Subjects:
Online Access:http://eprints.undip.ac.id/48504/
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02839 am a22002773u 4500
001 repository_undip_48504_
042 |a dc 
100 1 0 |a Taufiq, Fikri  |e author 
245 0 0 |a THE EFFECTS OF ALLOGENEIC MSC ADMINISTRATION ON ATHEROSCLEROTIC VESSEL WALL (EXPERIMENTAL STUDY OF TGF-β1, IL-1α, AND IL-6 ON ATHEROSCLEROTIC SPRAGUE DAWLEY RATS) 
260 |c 2014. 
500 |a http://eprints.undip.ac.id/48504/1/Cover.pdf 
500 |a http://eprints.undip.ac.id/48504/2/Chapter_1.pdf 
500 |a http://eprints.undip.ac.id/48504/3/Chapter_2.pdf 
500 |a http://eprints.undip.ac.id/48504/4/Chapter_3.pdf 
500 |a http://eprints.undip.ac.id/48504/5/Chapter_4.pdf 
500 |a http://eprints.undip.ac.id/48504/6/Chapter_5.pdf 
500 |a http://eprints.undip.ac.id/48504/7/Chapter_6.pdf 
500 |a http://eprints.undip.ac.id/48504/8/Chapter_7.pdf 
500 |a http://eprints.undip.ac.id/48504/9/References.pdf 
500 |a http://eprints.undip.ac.id/48504/10/Appendixes.pdf 
520 |a Background: Atherosclerosis is the leading cause of morbidity and mortality in the world. Mesenchymal stem cells (MSCs) are implicated in a variety of physiological and pathological processes. They may able to ameliorate atherosclerosis by interfering IL-1α, IL-6 and TGF-β1 expression. However, the effect of MSCs to them in atheroscherotic vessel wall has never been reported. Objective: To investigate the effect of intravenous administration of allogeneic MSCs on atherosclerotic vessel wall. Method: Sprague Dawley rats were divided into negative control group (standard diet, n=6), positive control group (atherosclerotic diet, n=6), and MSC treatment group (atherosclerotic diet and treated by single dose of 5x10 6 MSCs, n=8). MSCs were isolated by plastic adherent method from umbilical SD rats. Atherosclerotic event in abdominal aorta was stained by hematoxilin and eosin, while IL-1α, IL-6 and TGF-β1 expression were observed by immunohitochemistry. Results: Atherosclerotic plaque in the MSC treatment group was lower than in the positive control group(p=0.006). IL-1α and IL-6 expression in endothel, smooth muscle and macrophage of three groups were not different. TGF-β1 expression by macrophage inside vessel wall in MSC tretment group was lower than in positive control group (p=0.046), but there was no different of TGF-β1 expression in both endothel and smooth muscle. Conclusion: MSCs may have role in ameliorating atherosclerotic plaque in SD rats mediated in part by reducing of TGF-β1 expression in macrophage, but not by IL-1α and IL-6. Keywords: Mesenchymal stem cells, atherosclerosis, IL-1α, IL-6, TGF-β1 
690 |a R Medicine (General) 
655 7 |a Thesis  |2 local 
655 7 |a NonPeerReviewed  |2 local 
787 0 |n http://eprints.undip.ac.id/48504/ 
856 4 1 |u http://eprints.undip.ac.id/48504/